- Delivery Method:
- VIA Electronic Mail
- Reference #:
Recipient NameDakoda Collins
- California Vaping Company Inc.
- Issuing Office:
- Center for Tobacco Products
Dear Dakoda Collins:
The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses dated March 10, 2021, March 16, 2021, and May 19, 2021, in response to our Warning Letter dated February 26, 2021. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://calivapeco.com.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products
VIA Electronic Mail
Liquid Web, L.L.C